Trine Jakobi Nøttrup

Author

Also Known As

Gabriel Lindahl, Johanna Mäenpää, Nøttrup, Trine Jakobi, T. Jakobi Nøttrup, T. Nottrup, T. Nøttrup, T.J. Nottrup, T.J. Nøttrup, Trine J Nøttrup, Trine J. Nøttrup

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Copenhagen University Hospital Spanish Ovarian Cancer Research Group Centre Léon Bérard Kliniken Essen-Mitte

About

Trine Jakobi Nøttrup is an author at Rigshospitalet specializing in radiology, radiation oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	521
2	Medicine	2	2	422
3	Engineering	1	1	99
4	Biostatistics	1	1	99
5	Health Informatics	1	1	99

Trine Jakobi Nøttrup

Publications

935

Citations

H-Index

Page 1

	Year	Citations
Breathing adapted radiotherapy for breast cancer: Comparison of free breathing gating with the breath-hold technique Stine Korreman, Anders N. Pedersen, Trine Jakobi Nøttrup, Radiotherapy and Oncology Adaptive RadiotherapyRadiation TherapyMedicineBrachytherapyBreath-hold Technique	2005	262
Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer Stine Korreman, Anders N. Pedersen, Lasse Rye Aarup, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyPulmonary Complication ProbabilitiesMedicineBrachytherapy	2006	160
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study Magnus Pedersen, Marie Christine Wulff Westergaard, Katy Milne, OncoImmunology	2018	118
Respiratory motion prediction by using the adaptive neuro fuzzy inference system (ANFIS) Manish Kakar, Håkan Nyström, Lasse Rye Aarup, Physics in Medicine and Biology Artificial IntelligenceEngineeringMachine LearningFuzzy ModelingIntelligent Diagnostics	2005	99
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial Philipp Harter, Marie Ange Mouret‐Reynier, Sandro Pignata, Gynecologic Oncology	2021	85
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis Sana Intidhar Labidi‐Galy, Manuel Rodrigues, José Luís Sandoval, Annals of Oncology	2022	59
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial Domenica Lorusso, Marie‐Ange Mouret‐Reynier, Philipp Harter, International Journal of Gynecological Cancer	2023	51
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial Ursula A. Matulonis, Lydia Walder, Trine Jakobi Nøttrup, Journal of Clinical Oncology	2019	37
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial Céline Callens, Manuel Rodrigues, Adrien Briaux, Oncogene	2023	28
Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patients Sahar Ahangari, Naja Liv Hansen, Anders B. Olin, Acta Oncologica	2021	23

Page 1